Longford woman battling rare disease says HSE decision not to fund drug is 'shameful'

Kiara Lynch in her home on Thursday giving her reaction to the HSE decision.placeholder image
Kiara Lynch in her home on Thursday giving her reaction to the HSE decision. | Longford Leader

Both Kiara (42) and her older brother Liam, who is six years older, were diagnosed with Friedreich's Ataxia in 1997 and 1990 respectively.

A North Longford woman with a rare, neuromuscular disease, who is campaigning for access to life-changing treatment for her and 200 patients, has insisted the system for approving funding for new drugs 'is broken'.

Kiara Lynch, from Aughnagarron, Granard, was diagnosed with Friedreich's Ataxia (FA) at the age of 13 and for more than 28 years she has been battling 'the relentless progression' affecting all of her abilities.

The effects of Friedreich's Ataxia are having a significant adverse impact on her body and Kiara said she has 'cardiac issues, lung issues, bladder issues, pressure sores, and constant pain in my neck and back'.

Both Kiara (42) and her older brother Liam, who is six years older, were diagnosed with Friedreich's Ataxia in 1997 and 1990 respectively.

Kiara previously told the Longford Leader how there was a very welcome and much-needed glimmer of hope when the new drug treatment Skyclarys, the first treatment in the world for FA was approved.

Skyclarys or omaveloxolone was first given the green light for use in the US in 2023 and Europe followed less than 12-months later.

However, the 'game-changer' treatment, which costs approximately €280,000 per person, has been at the centre of protracted price negotiations between the HSE and the marketing authorisation holder, Biogen (Idec) Ireland Limited.

The HSE Drugs group recommended following a meeting last Tuesday that the ground-breaking drug should not be currently funded by the national health service.

Kiara said she was left devastated by the news and she believes the decision was 'shameful'.

“The whole system is clearly broken,” she added.

A total of 11 EU countries have approved the use of Skyclarys including Germany, France, Spain, Portugal, Greece, and Czechia.

Kiara said the decision in Ireland seems to be 'ultimately all about money' and there appears to be little consideration for the health and lives of her and the 200 people battling the disease.

"I have had to deal with the HSE all my adult life, and it has always been on the basis of them deciding what I need, rather than me getting to tell them what I need.

"I see the same thing happening with Skyclarys where I and everyone else with FA in Ireland is telling them we need this, they are telling us we can't have it, and they completely disregard our own research of talking to people with FA in other countries who do have the drug and are seeing the benefits."

It emerged on Friday that a large proportion of the non-ministerial Fianna Fáil members have criticised the HSE and signed a letter and raised "serious concerns" about the decision to refuse funding for Skyclarys.

The letter was signed by 48 TDs, senators, and MEPs - including one Minister of State and they described the approval system for drugs as being "broken and not fit for purpose".

Kiara does a minimum of three hours a day of physiotherapy but despite these significant efforts she believes her body is still deteriorating and being ravaged by FA.

"It's so shameful that we have to do this. Nobody should have to do this.

"The system is quite clearly broken," she added.

Kiara has described the HSE as being 'just an animal on their own'.

To read the full story see next week's Longford Leader

Powered by
Register
Follow us
© 2026 Formpress Publishing LTD. All rights reserved.Cookie SettingsTerms and ConditionsPrivacy notice